核医学在骨髓炎中角色的演变:当前证据与未来展望的叙述性综述
该叙述性综述聚焦原发性和继发性骨髓炎(重点为骨折相关感染、胸骨感染及感染播散评估),梳理从三相骨显像、白细胞显像到¹⁸F-FDG PET/CT及新兴技术的核医学应用。结论认为应根据具体临床场景整合闪烁显像与混合成像技术,未来正从非特异性炎症成像迈向病原体靶向的精准分子诊断。
要点
- 三相骨显像敏感性高但特异性低,适合初始筛查。
- 白细胞显像联合SPECT/CT特异性更优,是肌骨感染诊断基石。
- ¹⁸F-FDG PET/CT诊断准确性高,但术后无菌性炎症可干扰判读。
核心结论
- 整合闪烁显像与混合成像技术并针对具体临床场景选择,对骨髓炎准确诊断至关重要。
- 未来发展方向是从非特异性炎症成像转向精准的病原体靶向分子诊断。
研究设计与样本
- 本文为叙述性综述,围绕原发性和继发性骨髓炎,重点讨论骨折相关感染、胸骨感染及感染播散评估。
主要发现
- 三相骨显像仍是高敏感性的初始筛查工具,但特异性低限制其应用。
- 白细胞显像联合SPECT/CT特异性更优,被视为肌骨感染诊断的基石。
- ¹⁸F-FDG PET/CT诊断准确性高,尤其适用于骨折相关感染或感染播散评估。
- ¹⁸F-FDG PET/CT可受术后无菌性炎症干扰,但特定摄取模式和高阴性预测值具有临床价值。
- 动态PET采集、AI驱动图像增强和新型病原体特异性放射性示踪剂是新兴前沿方向。
关键数值与推荐
- 三相骨显像:高度敏感但特异性低。
- 白细胞显像联合SPECT/CT:特异性优于三相骨显像,为肌骨感染诊断基石。
- ¹⁸F-FDG PET/CT:诊断准确性高,阴性预测值高,但术后无菌性炎症可造成假阳性。
临床怎么用
- 骨髓炎诊断常需多模态成像,以区分感染与非感染性炎症。
- 初始筛查可选用三相骨显像,需更高特异性时选用白细胞显像联合SPECT/CT。
- 评估骨折相关感染或感染播散时可考虑¹⁸F-FDG PET/CT,并注意术后炎症的干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The diagnosis of osteomyelitis (OM) remains a significant clinical challenge, often requiring a multimodality imaging approach to differentiate infection from non-infectious inflammatory conditions. This review focuses on primary and secondary osteomyelitis, with particular emphasis on fracture-related infections, sternal infections, and the assessment of dissemination of infection using nuclear medicine techniques, from established scintigraphic methods to advanced hybrid imaging and emerging technologies. FINDINGS: While three-phase bone scintigraphy remains a highly sensitive initial screening tool, its utility is limited by low specificity. White blood cell (WBC) scintigraphy, particularly when combined with SPECT/CT offers superior specificity and is considered a cornerstone for diagnosing musculoskeletal infections. ¹⁸F-FDG PET/CT has emerged as a powerful modality with high diagnostic accuracy, especially for evaluating fracture-related infections or dissemination of infection. However, its performance can be confounded by sterile postsurgical inflammation, though specific uptake patterns and a high negative predictive value are clinically valuable. Emerging frontiers, including dynamic PET acquisition, AI-driven image enhancement, and novel pathogen-specific radiotracers, promise to overcome current limitations by improving specificity and providing biologically targeted information. CONCLUSION: The integration of scintigraphic and hybrid imaging techniques, tailored to the specific clinical scenario, is paramount for the accurate diagnosis of OM. Future developments are rapidly moving the field from non-specific inflammation imaging toward precise, pathogen-targeted molecular diagnostics.
引用
- Gatón-Ramírez J, Slart RHJA, Gheysens O, et al. The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons. Semin Nucl Med. 2026. PMID: 41916841. doi:10.1053/j.semnuclmed.2026.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。